Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
On November 5, 2002, the U.S
Pricing Disclaimer: All prices, program terms, and promotional offers mentioned were based on information published on the official Direct Meds website at the time of publication (March 2026) but are subject to change without notice
First approved by the FDA in 2005 with exenatide, these medications enhance insulin production post-meals, aiding in blood sugar control
Diabetes: Diabetes is associated with oxidative stress and inflammation, impacting the blood vessels throughout the body and the brain
Unlike native IGF-1, which requires frequent administration due to its short half-life and extensive IGFBP binding, IGF-1 LR3's enhanced stability and bioavailability make it a more practical candidate for investigating growth factor-mediated tissue regeneration and metabolic regulation
